PharmaEssentia Completes Patient Enrollment for Phase 2b EXCEED-ET Trial in Essential Thrombocythemia and Phase 3b ECLIPSE-PV Trial in Polycythemia Vera
“Myeloproliferative neoplasms, including ET and PV, are chronic blood diseases [...]
“Myeloproliferative neoplasms, including ET and PV, are chronic blood diseases [...]
Sterling Chung, Vice President of Regulatory Affairs and Quality at [...]
Golidocitinib is a first-in-class Janus kinase 1 (JAK1) only inhibitor [...]
Dale Levitzke, CEO of Sphere Fluidics, expressed his pride in [...]
Tianlong’s Biolum Portable ATP Hygiene Monitoring System, a powerful tool [...]
The grant was awarded through MJFF’s Parkinson’s Disease Therapeutics Pipeline [...]
Dr Kambiz Shekdar said: “I gratefully take this opportunity as [...]
“We celebrate the growing base of research and technological advances [...]
Through the HOPE Program, patients across the globe can receive [...]
The trial, which aimed to replicate and expand an earlier [...]